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Meeting Presentation: 12th Ocular Inflammation Society Congress, February 27th 28th and March 1st 2014, Valencia, Spain.Cumali Degirmenci a,⇑; Suzan Guven Yilmaz b; Melis Palamar b; Halil Ates bAbstractBilateral acute iris transillumination (BAIT) is a recently defined disease characterized with bilateral acute, severe pigment dispersion
of iris and pupil sphincter paralysis. The etiopathogenesis of the disease is unknown, but antibiotics such as moxifloxacin, clar-
ithromycin, viral infections, and fumigation therapies were considered as probable etiologic factors. A 33-year-old female was
referred to our clinic for acute iridocyclitis refractory to azathioprine, colchicum and corticosteroid treatments. Ophthalmic exam-
ination revealed bilateral pigment dispersion, significant iris transillumination, heavy pigment deposition in iridocorneal angle, and
elevated intraocular pressure. Upon systemic evaluation she was found to have bacterial urinary tract infection. BAIT is an important
cause of pigment dispersion and clinicians must be vigilant for this condition to avoid unnecessary diagnostic tests and treatment.
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Bilateral acute iris transillumination (BAIT) is a new clinical
entity characterized by severe transillumination of the iris,
acute onset of pigment dispersion in the anterior chamber,
and a mydriatic pupil that is unresponsive or poorly respon-
sive to light due to variable sphincter paralysis.1 The circulat-
ing pigment particles in the anterior chamber may be
confused with other conditions that also might lead to pig-
ment dispersion (such as pigment dispersion syndrome,
pseudoexfoliation syndrome, and iridocyclitis).2–4
Herein, we report a case with BAIT occurred after a bacte-
rial urinary tract infection misdiagnosed as acute iridocyclitis.
Case report
A 33-year-old female who was diagnosed as having acute
iridocyclitis refractory to systemic and topical treatment wasreferred to our clinic for second opinion. Upon arrival she
had blurred vision, redness, photophobia and pain in both
eyes. She was on topical prednisolone acetate (Pred forte,
Allergan, Westport Co., Mayo, Ireland) (8 times a day), sys-
temic methylprednisolone (Ultralan, Bayer Schering Pharma
AG, Germany) (1 mg/kg/day), systemic azathioprine (Imuran,
Glaxo Smithkline, United Kingdom) and colchicine (Colchium
dispert, Dr. F. Frik, Istanbul, Turkey) for 2 weeks. Best cor-
rected visual acuity was 20/25 in both eyes with intraocular
pressures (IOPs) of 30 mmHg in the right and 32 mmHg in
the left eye. Ophthalmic examination revealed bilaterally 4+
pigment dispersion in the anterior chamber, symmetrical dif-
fuse iris transillumination, and pigment deposition on the cor-
neal endothelium (Fig. 1A and B). Gonioscopy demonstrated
dense pigment obscuring all iridocorneal angle components
(Fig. 1C and D). Anterior segment optical coherence tomog-
raphy (3D OCT-2000, Topcon Corporation, Tokyo, Japan)
demonstrated no iris concavity (Fig. 1E and F). Posteriore:
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Figure 1. (A and B) Anterior segment photographs show significant iris transillumination, (C and D) gonioscopy reveals heavy pigment deposition in
iridocorneal angle, (E and F) anterior segment OCT images demonstrated no backward bowing of the iris. (G and H) Retinal nerve fiber layer thickness
and optic nerve photographs.
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no glaucomatous defect was detected (Fig. 1G and H). Pupils
were mydriatic and poorly responsive to light. The patient
underwent a detailed laboratory evaluation including liver
enzymes, blood urea nitrogen, creatinine, erythrocyte sedi-
mentation rate, C-reactive protein, and viral serology. Serum
IgG and IgM antibodies against Epstein-Barr virus, Cytome-
galovirus, Herpes Simplex virus and Varicella Zoster virus
were evaluated. The serological results showed that IgM anti-
bodies were negative for all of these microorganisms and IgG
antibodies were positive but not elevated for all. In complete
blood count, neutrophilic leukocytosis was detected andurine analyses and urine microscopy supported bacterial uri-
nary tract infection which was confirmed by an urologist. The
etiological agent – confirmed by urine culture – was Escheri-
chia coli. The remaining tests were within normal limits.
Systemic corticosteroid was discontinued and topical cor-
ticosteroid was tapered to 4 times a day. Bilateral topical dor-
zolamide/timolol fixed combination (Cosopt, Merck Sharp &
Dohme, Paris, France) two times a day was started. With the
decrement of IOP to 12/14 mmHg, pigment dispersion
decreased gradually and disappeared completely within
2 weeks. Anti-glaucomatous treatment was stopped and
IOPs remained within normal limits. At this point steroid
124 C. Degirmenci et al.induced glaucoma was excluded. However, bilateral mydri-
atic pupillae poorly responsive to light and iris transillumina-
tion resisted. The patient was followed up for 20 months and
in this period IOPs were within normal limits with no medica-
tion. Optic nerve analyses showed no glaucomatous defect.
No other pigment dispersion attack was experienced. These
findings suggested the diagnosis of BAIT.
Discussion
A large case series have recently been reported with an
unusual bilateral acute iris transillumination, associated with
symptomatic pigment showering after an upper respiratory
tract infection.1 This syndrome has been named as BAIT
and demonstrates self-limiting features as in our case. Symp-
toms of our patient masqueraded acute iridocylitis and ocular
findings overlapped pigment dispersion syndrome. Pigment
deposition in the trabecular meshwork explained the early
IOP rise.
BAIT and pigment dispersion syndrome resemble each
other. Both of the diseases affect young people, and usually
pigment deposition in the iridocorneal angle is dense and
homogeneous. Also iris transillumination is symmetrical. But
the onset of the disease in pigment dispersion syndrome is
silent and disease progresses slowly in contrast to abrupt
and symptomatic beginning in BAIT. And also transillumina-
tion defects are always in spoke like pattern because of the
disease pathogenesis. Moreover pigment deposition on
anterior surface of the lens and iris stroma might also be
seen. Anterior segment examination and gonioscopy reveal
iris concavity toward anterior surface of the lens. Pupil reac-
tions to light in pigment dispersion syndrome are normal
but in BAIT the presence of pupillary atony and distorted
pupils are essential properties.2
The differential diagnosis of BAIT also includes acute irido-
cyclitis and pseudoexfoliation syndrome. Acute iridocyclitis is
characterized by cellular extravasation and protein exudation
in the anterior chamber. Posterior synechiae is also an impor-
tant property of this entity. In the present case BAIT was mis-
taken for acute iridocyclitis and was tried to be treated with
systemic steroids and immunomodulators. Pseudoexfoliation
syndrome is also featured as transillumination defects around
pupils; however, on slit lamp examination, fibrillar material
accumulation on lens surface and iris sphincter is the hallmark
of this entity. Additionally pseudoexfoliation syndrome is
usually unilateral at the time of the diagnosis and is seen in
older patients.3,4
Herpes simplex virus and cytomegalovirus also may cause
iris atrophy and pupillary atony. Although IOP elevation and
atonic pupils were seen as well, symmetrical and bilateralinvolvement of iris, and absence of keratic precipitates
ensure us to think about BAIT for diagnosis. Furthermore a
newly defined clinical entity by Tugal-Tutkun and Urgan-
cioglu5 Bilateral Depigmentation of Iris (BADI) should be con-
sidered in the differential diagnosis. The most important
features to differentiate these diseases are the unaffected
pupil and the absence of transillumination defect in BADI.
The pathophysiology of BAIT still remains unclear. Recently,
in a few reports, antibiotics such as moxifloxacin, clar-
ithromycin and fumigation therapies have been impli-
cated.6–8 Tugal-Tutkun et al.1 reported the largest series
about this syndrome in 2011. According to the report, BAIT
is a distinct disease and it is triggered by a viral infection
not by antibiotic use. In our patient clinical findings were suit-
able with BAIT but there was not any medication use or viral
infection. However, the patient had an ongoing bacterial uri-
nary tract infection proven with laboratory testing. Probably,
triggering factors are not only viral but also bacterial infec-
tions. However, more cases with further evaluations are
needed to enlighten the exact etiology.
In conclusion, to avoid unnecessary diagnostic evaluation
and treatment, clinicians should recall BAIT syndrome to
mind in the differential diagnosis of iridocyclitis and pigment
dispersion.
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